PANDION THERAPEUTICS, INC. Stock-Based Compensation
PANDION THERAPEUTICS, INC. reported Stock-Based Compensation of $2.65 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2021-03-12
- PANDION THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-12-31 was $1.11M, a 1718.03% increase year-over-year.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-09-30 was $1.33M, a 3302.56% increase year-over-year.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $61.00K.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $39.00K.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2020 was $2.65M, a 2105.00% increase from fiscal 2019.
- PANDION THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $120.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.44M derived: sum of 2 quarters · filed 2021-03-12 | $2.65M 10-K · filed 2021-03-12 | |
| 2020-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $1.54M 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $210.00K 10-Q · filed 2020-08-31 | |||
| 2019-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $100.00K derived: sum of 2 quarters · filed 2021-03-12 | $120.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $59.00K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $20.00K 10-Q · filed 2020-08-31 |